Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivation.

Saved in:
Bibliographic Details
Title: Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivation.
Authors: Stervbo U; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany.; BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Anft M; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Paniskaki K; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Blazquez-Navarro A; BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Doevelaar A; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Skrzypczyk S; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Kohut E; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Kurek J; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Wehler P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Center for Advanced Therapies, Augustenburger Platz 1, 13353, Berlin, Germany., Kaliszczyk S; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Rosiewicz K; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Seibert FS; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Hölzer B; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Thieme CJ; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Center for Advanced Therapies, Augustenburger Platz 1, 13353, Berlin, Germany., Roch T; BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Konik MJ; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Berger MM; Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Brenner T; Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Kölsch U; Department of Immunology, Labor Berlin GmbH, Sylter Straße 2, 13353, Berlin, Germany., Adamzik M; Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, In der Schornau 23-25, 44892, Bochum, Germany., Schmueck-Henneresse M; BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany., Scheibenbogen C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Center for Advanced Therapies, Augustenburger Platz 1, 13353, Berlin, Germany.; Department of Immunology, Labor Berlin GmbH, Sylter Straße 2, 13353, Berlin, Germany., Dolff S; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Dittmer U; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Germany., Westhoff TH; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany., Babel N; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany. nina.babel@charite.de.; BIH Center for Regenerative Therapies (BCRT), Experimental Immunotherapy, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. nina.babel@charite.de.
Source: Medical microbiology and immunology [Med Microbiol Immunol] 2026 Apr 20; Vol. 215 (1). Date of Electronic Publication: 2026 Apr 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0314524 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1831 (Electronic) Linking ISSN: 03008584 NLM ISO Abbreviation: Med Microbiol Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1831
DOI:10.1007/s00430-026-00873-3